APA (7th ed.) Citation
(2026). Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study. Journal of Asthma and Allergy.
Chicago Style (17th ed.) Citation
"Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study." Journal of Asthma and Allergy 2026.
MLA (9th ed.) Citation
"Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study." Journal of Asthma and Allergy, 2026.
Warning: These citations may not always be 100% accurate.